NCT04592055

Brief Summary

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

October 16, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 19, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

May 4, 2021

Status Verified

May 1, 2021

Enrollment Period

7 months

First QC Date

October 16, 2020

Last Update Submit

May 1, 2021

Conditions

Diabetes MellitusCovid19

Outcome Measures

Primary Outcomes (1)

  • A1c

    the change in A1c levels

    6 months (3 months before and after COVID-19

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled and evaluated.

You may qualify if:

  • \- All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.

You may not qualify if:

  • \- The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usak University Training and Research Hospital

Uşak, 64200, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Diabetes MellitusCOVID-19

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Cevdet Duran, Prof

    Uşak University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cevdet Duran

CONTACT

02762212121drcduran@gmail.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2020

First Posted

October 19, 2020

Study Start

March 20, 2020

Primary Completion

October 15, 2020

Study Completion

July 1, 2021

Last Updated

May 4, 2021

Record last verified: 2021-05

Locations

TU(1)